Current consensus and controversies on male LUTS/BPH (part two).
作者信息
Foo Keong Tatt
机构信息
Department of Urology, Singapore General Hospital, Singapore.
出版信息
Asian J Urol. 2018 Jan;5(1):8-9. doi: 10.1016/j.ajur.2017.11.007. Epub 2017 Dec 6.
Abstract
摘要
相似文献
1
Current consensus and controversies on male LUTS/BPH (part two).
Asian J Urol. 2018 Jan;5(1):8-9. doi: 10.1016/j.ajur.2017.11.007. Epub 2017 Dec 6.
2
Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia.
Tzu Chi Med J. 2017 Jan-Mar;29(1):6-11. doi: 10.4103/tcmj.tcmj_3_17.
3
Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia.
Tzu Chi Med J. 2017 Jan-Mar;29(1):1-5. doi: 10.4103/tcmj.tcmj_2_17.
4
Current consensus and controversies on male LUTS/BPH (part one).
Asian J Urol. 2017 Jul;4(3):137. doi: 10.1016/j.ajur.2017.06.005. Epub 2017 Jun 15.
5
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
BJU Int. 2015 Apr;115(4):508-19. doi: 10.1111/bju.12745. Epub 2014 Oct 16.
6
Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.
Int J Clin Pract. 2011 Sep;65(9):1005-13. doi: 10.1111/j.1742-1241.2011.02731.x. Epub 2011 Jul 1.
7
[Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Prog Urol. 2015 Jun;25(7):404-12. doi: 10.1016/j.purol.2015.02.008. Epub 2015 Apr 2.
8
Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
BJU Int. 2005 Jun;95 Suppl 4:12-8. doi: 10.1111/j.1464-410X.2005.05486.x.
9
[Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].
J Prev Med Public Health. 2006 Mar;39(2):141-8.
10
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29.
本文引用的文献
1
Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?
Asian J Urol. 2018 Jan;5(1):48-54. doi: 10.1016/j.ajur.2017.12.001. Epub 2017 Dec 8.
2
Non-invasive evaluation of lower urinary tract symptoms (LUTS) in men.
Asian J Urol. 2018 Jan;5(1):42-47. doi: 10.1016/j.ajur.2017.12.002. Epub 2017 Dec 8.
3
Laparoscopic adenomectomy in BPH - Does it have a role today?
Asian J Urol. 2018 Jan;5(1):37-41. doi: 10.1016/j.ajur.2017.11.008. Epub 2017 Dec 6.
4
Botulinum toxin and benign prostatic hyperplasia.
Asian J Urol. 2018 Jan;5(1):33-36. doi: 10.1016/j.ajur.2017.11.003. Epub 2017 Nov 22.
5
The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.
Asian J Urol. 2018 Jan;5(1):28-32. doi: 10.1016/j.ajur.2017.11.005. Epub 2017 Nov 26.
6
Update on minimally invasive surgery and benign prostatic hyperplasia.
Asian J Urol. 2018 Jan;5(1):22-27. doi: 10.1016/j.ajur.2017.06.001. Epub 2017 Jun 9.
7
Underactive bladder: Pathophysiology and clinical significance.
Asian J Urol. 2018 Jan;5(1):17-21. doi: 10.1016/j.ajur.2017.02.003. Epub 2017 Apr 13.
8
Innovative endoscopic enucleations of the prostate - Xie's Prostate Enucleations.
Asian J Urol. 2018 Jan;5(1):12-16. doi: 10.1016/j.ajur.2017.11.001. Epub 2017 Nov 20.
9
Commentary on "Solving the benign prostatic hyperplasia puzzle".
Asian J Urol. 2018 Jan;5(1):10-11. doi: 10.1016/j.ajur.2016.09.007. Epub 2016 Sep 20.
Zotero 插件